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Abstract 
The disulfide bridges of toxin 2 from the venom of the scorpion Centruroides noxius Hoffmann were found by amino acid sequence determination 
of fragments of native toxin, produced by enzymatic cleavage and separated by high-performance fiquid chromatography (HPLC). They are: 
CystZ-Cys 65, Cys16-Cys 41, Cys25-Cys *  and Cys~-Cys ~. The coordinates ofthe X-ray diffraction structure of toxin variant 3 of C. sculpturatus [(1980) 
Proc. Natl. Aead. Sci. USA 77, 6496--6500] were used to construct a three-dimensional model of toxin 2. All the amino acid replacements were easily 
accommodated, and the modeled structure reveals a clustered pattern of sequence variation, which may help to identify residues responsible for 
functional differences among toxins of mammals and insects. 
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1. Introduction 3. Results and discussion 
To elucidate the structure-function relationships of 
scorpion toxins and their targeted ion channels [2] more 
information is needed, not only on their primary struc- 
ture, of which many are known [3,4], but also on their 
three-dimensional folding [1,5]. One of the structural fea- 
tures of the Na ÷ channel-directed toxins is the high con- 
tent of disulfide bridges, but few disulfide pairs have been 
directly determined [1,5,6]. Here we describe the experi- 
mental determination of the disulfide bridges of toxin 2, 
a mammalian-specific toxin. We also present a model of 
its three-dimensional structure, based on the crystal 
structure of its insect-specific homologue, variant 3 of 
C sculpturatus [1]. Insights into possible structure-func- 
tion relationships are discussed. 
2. Material and methods 
Toxin 2 was purified as described by Zamudio et al. [7]. This peptide 
(1.2 rag, equivalent to 170 nmol) was hydrolysed by chymotrypsin a d 
trypsin, and separated by HPLC, following the procedure of Sugg et 
al. [8]. Heterodimeric peptides containing the native disulfide bridges 
were identified by microsequencing i  a Millipore ProSequencer [7]. 
Since the primary structure of this toxin is known it was easy to assign 
its disulfide pairing. 
Computational analysis made use of the coordinates ofvariant 3 of 
the related scorpion C sculpturatus [1]. The suit of programs for homol- 
ogy modeling from Biosym Technologies (San Diego, USA) was used 
for model generation (including minimiTation, and molecular dynamics 
at 400 K for 5 ps and then 5 ps at 300 K). A water shell was included. 
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The few experimentally determined isulfide bridge 
patterns of Na + channel-specific s orpion toxins are 
those of variant 3from C sculpturatus [1], toxin M9 from 
Buthus eupeus [5], toxin III and toxin II [5,6], from An- 
droctonus australis, a typical 0~-scorpion toxin [9]. The 
disulfide bridges of these toxins all correspond to equiv- 
alent positions on the primary structure (Cyst2-Cys 65, 
Cys16-Cys 4~, Cys25-Cys4~ and Cys29-Cys4S), except for the 
insect oxin I from A. australis [10], which has the pairing 
Cys16-Cys 37, Cys22-Cys 42, Cys26-Cys 44, and Cys3S-Cys 64. 
Toxin 2 from C noxius [7], initially called component 
1I-9.2.2 [11], was shown to recognize Na + channels of 
several tissues [12-14]. This toxin is a typical fl-scorpion 
toxin [15]. 
Since the species pecificity and the fine mechanism of
action of insect, and mammalian ~- and fl-scorpion tox- 
ins are different, we decided to determine the relative 
positions of the disulfides of toxin 2 from C noxius. 
Separation of enzymatically cleaved peptides of native 
toxin 2 gave rise to approximately 30components when 
applied to a Cls reverse-phase column on HPLC (data 
not shown). Under sequence analysis, peptides that 
eluted at 47.15 min (step-gradient 9.82 min), 59.28 (8.51), 
64.36 (8.28) and 68.76 min gave two amino acids each at 
every step of the microsequencing process. The values in 
parenthesis after the time (min) mean that the same com- 
ponent before sequencing was further applied to HPLC 
and eluted at the time indicated, when using a continuous 
gradient mode (step-gradient). Since the primary struc- 
ture of toxin 2 was known [7], this allowed us to assign 
the the disulfide pairing unequivocally (Table 1). The 
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Fig. 1. Stereo-image of the three dimensional models of toxin 2 from C noxius (CN2), and variant 3 of C sculpturatus (SN3). Coordinates for variant 
3 of C. sculpturatus (Brookaven data b nk lsn3) were used for modeling the Cn2 structure, using a Silicon-Graphics IRIS 4D/35 and a Cray 
Y-MP4/464; with programs from Biosym Technologies Inc. Energy minimization, and molecular dynamics at 400 K for 5 ps and then 5 ps at 
300 K were employed to refine the model; a water shell 5 A thick was included. NI-I 2- and COOH-termini are indicated. Variant amino acids (one 
letter code) are represented as ball and stick side chains, protruding from the main chain represented as a solid ribbon. Disulfide ridge-forming atoms, 
used as a reference, are represented by ark sticks, and labeled with numbers corresponding to the cysteines involved. Other identical mino acids 
are not shown. The complete primary structure of these two proteins is shown in Table 1. 
relative positions of the disulfide bridges of toxin 2 corre- 
spond to equivalent positions in variant 3 of C. sculptura- 
tus [1] and toxin I I  from A. australis [6]. 
We next modelled the structure of toxin 2 of C. noxius, 
using the available coordinates of the three-dimensional 
structure of variant 3 (Brookhaven entry 1SN3, from the 
original reference of Fontecilla-Camps et. al. [1]). The 
alignment of the two sequences was straightforward and 
the amino acid residues of toxin 2 were substituted on the 
SN3 structure. A simple energy minimization protocol 
revealed very good compatibility of the toxin 2 sequence 
with that of SN3 structure. In order to have a slightly 
better sampling of conformational space we also con- 
ducted limited molecular dynamics simulations which 
further adjusted the model to a sterically plausible one. 
Inspection of the model in Fig. 1 shows the preservation 
of a face rich in aromatic residues (corresponding to the 
front of the 'hand model' proposed by Fontecilla-Camps 
et al. [ 1], shown here facing away from the viewer). The 
figure uses a ribbon representation, in which only the 
side chain corresponding to variable amino acids are 
shown as stick representations. Numerous amino acid 
differences between the two toxins occur mainly towards 
the opposite face (back of the hand model, facing to- 
wards the viewer in the figure). For example, in CN2 
there are charged amino acids, such as glutamic acid at 
position 15 (GluXS), and Arg 64, facing this side, which 
replace, respectively, Gly '5 and Ser 64, present in SN3. 
Also noteworthy is the substitution of Asp 7 in CN2 for 
Lys 7 of SN3, which faces the front of the hand, at the 
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Table 1 
Amino acid sequence of heterodimeric peptides corresponding to the disulphide bridges of toxin 2 
61 
Elut ion t ime HPLC Amino Acid Sequence Corresponding disul f ide 
1 2 3 4 5 6 
47.15 (9.82) min Asn-Thr-Gly-CYS-Lys-Tyr  
Xxx-Ser 
Cys12-Cys65 
1 2 3 4 5 
59.28 (8.51) min GIu-CYS-Lys Cys29-Cys48 
Xxx-Thr-His-Leu-Tyr  
1 2 3 
64.36 (8.28) min GIu-CYS-Leu Cys16-Cys41 
Xxx-Tyr 
1 2 3 
68.67 min Xxx-Leu-Arg Cys25-Cys46 
AIa-CYS-Trp 
1 i0 20 30 40 50 60 
CN2 KEGYLVDKNTGCKYECLKLGDND¥CLRECKQQGYKGAGG¥CYAFACWCTHLYEQAIVWPLPNKRCS 
SN3 KEGYLVKKSDGCKYGCLKLGENEGCDTECKAKNQGGSYGYCYAFACWCEGLPESTPTYPLPNKSC 
Amino acid sequences were obtained by microsequencing peptides purified by HPLC after cleavage with chymotrypsin and trypsin. Numbers on 
top of the amino acid mean the positions in the sequence; Xxx, blank position corresponding to a 1/2 Cys residue (cysteine); CYS, position of a cysteine 
residue (usually in our machine we can identify a component that absorbs at 330 nm which corresponds to this amino acid). The two bottom lines 
contain the complete primary structure of CN2, as determined by Zamudio et al. [7], and SN3, as corrected by FonteciUa-Camps et al. [1]. Cysteinyl 
residues are printed in bold. 
bottom center of Fig. 1. From observation of Fig. 1 it 
seems that the portion facing forward at the back of the 
hand of these two molecules may play an important role 
in defining species specificity. On the other hand, the 
analysis made earlier by Kobayashi et al. [16] shows 
another important structural feature of the scorpion tox- 
ins. The spatial arrangement of these toxins seems to 
follow the same pattern: they all have the same general 
motif, around which many variants have been con- 
structed by natural selection [17]; the only highly con- 
served residues are the cysteines [16]. Thus the substitu- 
tions of amino acids in key positions of the toxin, at the 
protruding J- and B-loops, located, respectively, at rela- 
tive positions 15-25 and 40-45 [18]), and at the confluent 
N- and C-terminal regions of the molecules [1,5,10], seem 
to be important structural determinants of the species 
specificity and/or fine mechanism of action of these tox- 
ins (eg. 0c- vs. fl-scorpion toxins), as already noted [4]. 
Loret et al. [19] have proposed that the species specificity 
might reside in the C-terminal region of the molecule. 
Toxins having proline-rich segments at the C-terminus 
are thought o be more rigid, so they would not fit well 
into the binding sites of the Na + channels of mammals, 
while those having a more flexible C-terminus, like 
7/-toxin (toxin VII) from Tityus serrulatus [19], can recog- 
nize the Na + channel of either mammals or insects. 
Although chemical modification of lysine at position 
56 of toxin II from A. australis [20] showed it to be 
crucial for toxicity, the study of the structure-function 
relationship of Na + channel scorpion toxins is less ad- 
vanced than in other toxins, such as charybdotoxin, a K + 
channel toxin [21]. Park and Miller [21] showed by ge- 
netic engineering that a single lysine residue at position 
27 was fundamental to toxin activity. Also, Gurrola et 
al. [22] and Vaca et al. [23] have found that the N- 
terminal segment of noxiustoxin, another K + channel 
scorpion toxin, was important for its toxicity. The latter 
authors showed that a synthetically prepared nonapep- 
tide of noxiustoxin was sufficient for channel recognition 
and modulation. 
Thus, concerning the species specificity of Na + channel 
scorpion toxins, chemical or genetic modifications of the 
residues discussed above should still be conducted before 
a clear-cut picture can emerge. The construction and 
expression of artificially mutated toxins, by genetic engi- 
neering of the cloned cDNA genes [24-26], should allow 
the hypotheses discussed above to be tested. 
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